Diphtheria
📧 Sign up to get email alerts when something new happens for Diphtheria.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-05-09Clinical Trial Update: Immune Response followingTdap Vaccine in Pregnancy
This clinical trial update reports on the immune response following administration of the Tdap vaccine during pregnancy. The study, sponsore…
-
CLINICAL_TRIALS research · 2025-04-17Clinical Trial Update: Study of Concomitant Administration of the sIPV and DTaP or MMR [Phase 4]
Phase 4 trial evaluating concomitant administration of Sabin inactivated polio vaccine (sIPV) with DTaP or MMR vaccines; sponsored by the In…
-
CLINICAL_TRIALS research · 2025-04-03Clinical Trial Update: A Clinical Trial of Adsorbed Cell-free DPT Vaccine (5-component) (for People Aged 6 Years and Above) [Phase 1]
This document provides a status update on a Phase 1 clinical trial of an adsorbed cell-free five-component DPT vaccine for people aged 6 yea…
-
CLINICAL_TRIALS trial_result · 2025-03-24Clinical Trial Update: Study of Live Attenuated Varicella Vaccine Co-administered with MMR Vaccine or DTaP Vaccine [Phase 4]
Phase 4 trial update evaluating a live attenuated varicella vaccine co-administered with MMR or DTaP vaccines; study status is NOT_YET_RECRU…
-
CLINICAL_TRIALS trial_result · 2025-03-20Clinical Trial Update: Sero-epidemiological Survey of England in 2019/2020 - COVID-19
Completed sero-epidemiological survey in England (2019/2020) examining COVID-19 alongside serogroup C meningococcal meningitis and diphtheri…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-03-17Clinical Trial Update: A Clinical Trials of Adsorbed Cell-free DPT Vaccine (Five-component) [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial of an adsorbed cell-free five-component DPT vaccine conducted by CanSino Biologics Inc. is currently active…
-
CLINICAL_TRIALS trial_result · 2025-03-17Clinical Trial Update: A Clinical Trial of Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed(DTcP) [Phase 3]
Phase 3 clinical trial update for a diphtheria, tetanus and acellular pertussis vaccine adsorbed (DTcP) developed by CanSino Biologics; the …
-
CLINICAL_TRIALS trial_result · 2025-01-06Clinical Trial Update: Confirmatory Study of BK1310 in Healthy Infants [Phase 3]
A Phase 3 confirmatory trial of BK1310 in healthy infants evaluating protection against tetanus, diphtheria, pertussis, poliomyelitis, and b…
-
CLINICAL_TRIALS research · 2024-11-15Clinical Trial Update: Phase I/II, Open Label, Randomized, Safety and Immunogenicity Following DTwP-Hepatitis B-Hib-IPV Vaccine (Bio Farma) in Indonesian Infants [Phase 1, Phase 2]
Clinical trial update on a Phase 1/2 safety and immunogenicity study of a pentavalent DTwP-HepB-Hib-IPV vaccine in Indonesian infants; the t…
-
CLINICAL_TRIALS trial_result · 2024-11-12Clinical Trial Update: Study of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and Infants [Phase 2]
Phase 2 trial evaluating safety and immunogenicity of a pneumococcal conjugate vaccine when administered concomitantly with routine pediatri…
-
CLINICAL_TRIALS research · 2024-10-01Clinical Trial Update: Study to Evaluate the Immunogenicity of LR20062 Compared to Control When Administered Intramuscularly in Healthy Infants At 2, 4, 6 Months of Age [Phase 2]
Phase 2 trial to evaluate the immunogenicity of LR20062 versus control in healthy infants at 2, 4, and 6 months of age. The study targets pr…
-
CLINICAL_TRIALS research · 2024-09-20Clinical Trial Update: Safety and Immunogenicity of DTaP-IPV/Hib Pentavalent Vaccine in Chinese 2-month-old Infants [NA]
This clinical trial is evaluating the safety and immunogenicity of a pentavalent DTaP-IPV/Hib vaccine in 2-month-old Chinese infants; the st…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Clinical Study to Assess the Immunogenicity and Safety of Hexavalent Vaccine Containing Reduced Dose IPV [Phase 3]
This document reports a Phase 3 clinical trial evaluating the immunogenicity and safety of a hexavalent vaccine that contains a reduced-dose…
-
CLINICAL_TRIALS research · 2024-05-28Clinical Trial Update: Pertussis Vaccination Among HIV-infected and HIV-uninfected Pregnant Women [Phase 4]
A Phase 4 clinical trial update on pertussis vaccination in HIV-infected and HIV-uninfected pregnant women using the DTaP vaccine. The study…
-
CLINICAL_TRIALS trial_result · 2024-04-03Clinical Trial Update: Immunogenicity and Safety of Diphtheria, Tetanus, Pertussis (DTaP) Vaccine in 3-month-old Infants [Phase 3]
Phase 3 trial update evaluating immunogenicity and safety of a diphtheria, tetanus, and pertussis vaccine in 3-month-old infants; currently …
-
CLINICAL_TRIALS trial_result · 2024-03-27Clinical Trial Update: A Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK)'s Infanrix Hexa Vaccine (DTPa-HBV-IPV/Hib) Versus MCM Vaccine BV's Vaxelis Vaccine (DTaP5-HBV-IPV-Hib) in Healthy Infants and Toddlers [Phase 4]
Phase 4 study comparing immunogenicity and safety of GlaxoSmithKline's Infanrix Hexa (DTPa-HBV-IPV/Hib) versus MCM Vaccine BV's Vaxelis (DTa…
-
CLINICAL_TRIALS trial_result · 2024-02-05Clinical Trial Update: Immunogenicity and Safety of Vaccine Against Tetanus and Diphtheria. [Phase 3]
Phase 3 trial update evaluating immunogenicity and safety of a tetanus and diphtheria vaccine.
-
CLINICAL_TRIALS trial_result · 2023-09-06Clinical Trial Update: Safety, Tolerability, and Immunogenicity of Vaxelis™ in Children Previously Vaccinated With Vaxelis™ or Hexyon™ (V419-016) [Phase 4]
Phase 4 study assessing safety, tolerability, and immunogenicity of the hexavalent vaccine Vaxelis in children previously vaccinated with Va…
-
CLINICAL_TRIALS trial_result · 2023-06-28Clinical Trial Update: Vaccine -diphthEria -tetaNus -Acellular pertUssis-inactivated polioviruS [Phase 3]
Phase 3 trial update for a diphtheria-tetanus-acellular pertussis-inactivated poliovirus combination vaccine were completed.
-
CLINICAL_TRIALS trial_result · 2023-03-10Clinical Trial Update: Study to Evaluate the Immunogenicity and Safety of LBVD(Hexavalent Vaccine), Given to Healthy Infants at Primary Series [Phase 2, Phase 3]
Phase 2/3 clinical trial evaluating the immunogenicity and safety of LBVD(Hexavalent Vaccine) in healthy infants as part of the primary seri…
-
CLINICAL_TRIALS trial_result · 2023-01-20Clinical Trial Update: Study on the Safety and Immunogenicity of Boostrix Vaccine in Pregnant Malian Women and Their Infants [Phase 2]
A Phase 2 clinical trial evaluating the safety and immunogenicity of the Boostrix vaccine in pregnant Malian women and their infants, with r…
-
CLINICAL_TRIALS trial_result · 2022-04-25Clinical Trial Update: DTaP-IPV/Hib Vaccine Primary & Booster Vaccinations Versus Co-administration of DTaP-IPV and Hib Vaccine in Japanese Infants [Phase 3]
Phase 3 trial comparing primary and booster DTaP-IPV-Hib vaccinations to co-administration of DTaP-IPV and Hib in Japanese infants; study co…
-
CLINICAL_TRIALS trial_result · 2022-04-05Clinical Trial Update: Immunogenicity and Safety of Sanofi Pasteur's Combined Vaccine Given as a Three-Dose Primary Series at 2, 3,4 Months of Age and Followed by a Booster Dose Given at 16 to 17 Months of Age in Vietnamese Infants Who Previously Received a Dose of Hepatitis B Vaccine at Birth or Within 1 Week After Birth [Phase 3]
Phase 3 trial update evaluating the immunogenicity and safety of Sanofi Pasteur's combined vaccine given as a three-dose primary series in i…
-
CLINICAL_TRIALS trial_result · 2022-04-05Clinical Trial Update: DTaP-IPV-HB-PRP-T Combined Vaccine as a Primary Series and a Second Year of Life Booster in HIV-Exposed Infected and Uninfected Infants [Phase 3]
Phase 3 clinical trial evaluating DTaP-IPV-HB-PRP-T as a primary series and a second-year booster in HIV-exposed infants (infected and uninf…
-
CLINICAL_TRIALS trial_result · 2020-11-20Clinical Trial Update: To Evaluate the Immunogenicity and Safety of 'BR-TD-1001' Administered Intramuscularly in Healthy Children [Phase 3]
Phase 3 trial assessing immunogenicity and safety of BR-TD-1001 given intramuscularly in healthy children completed.